Evaluation of Prognostic Factors and Survival Results in Pancreatic Carcinomas in Turkey

Canyilmaz, Emine; Serdar, Lasif; Uslu, Gonca Hanedan; Soydemir, Gulsen; Bahat, Zumrut; Yoney, Adnan

추천

검색

자료유형: 학술저널

저자정보: Canyilmaz, Emine (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University) Serdar, Lasif (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University) Uslu, Gonca Hanedan (Department of Radiation Oncology, Kanuni Research and Education Hospital) Soydemir, Gulsen (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University) Bahat, Zumrut (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University) Yoney, Adnan (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제11호

발행연도: 2013.1

수록면: 6,573 - 6,578 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: The goal of this retrospective study was to evaluate patient characteristics, treatment modalities and prognostic factors in Turkish patients with pancreatic cancer. Materials and Methods: Between January 1997 and December 2012, 64 patients who presented to the Department of Radiation Oncology, Karadeniz Technical University, Faculty of Medicine with a diagnosis of pancreatic cancer were evaluated. The E/K ratio of the cases was 2.4/1 and the median age was 59.6 (32-80) years, respectively. Some 11 cases (18%) were stage 1, 21 (34.4%) were stage 2, 10 (16.4%) were stage 3, and 19 (31.1%) were metastatic. Results: The mean follow-up time was 15.7 months (0.7-117.5) and loco-regional recurrence was noted in 11 (40.7%) who underwent surgery while metastases were observed in 41 patients (66.1%). The median overall survival (OS) was 11.2 months and the 1, 3 and 5-year OS rates were 41.7%, 9.9% and 7.9% respectively. The median disease-free survival (DFS) was 5.2 month and the1, 2 and 5 year DFS were 22.6%, 7.6% and 3.8% respectively. On univariate analysis, prognostic factors affecting OS included status of the operation (p<0.001), tumor stage (p=0.008), ECOG performance status (p=0.005) and CEA level (p=0.017).On multivariate analysis, prognostic factors affecting survival included status of the operation (p=0.033) and age (p= 0.023). Conclusions: In the current study, age and operation status were independent prognostic factors for overall survival with pancreatic patients. Thus, the patients early diagnosis and treatment ars essential. However, prospective studies with more patients are needed for confirmation.

#Pancreatic cancer #radiotherapy #chemotherapy #CEA

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Canyilmaz, Emine

소속기관 Department of Radiation Oncology, Faculty of Medicine, Trabzon, Karadeniz Technical University